1921
Volume 100, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0771a
2019-02-06
2019-03-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/2/tpmd180771a.html?itemId=/content/journals/10.4269/ajtmh.18-0771a&mimeType=html&fmt=ahah

References

  1. Schneiderman AI, Cypel YS, Dursa EK, Bossarte RM, , 2018. Associations between use of antimalarial medications and health among U.S. veterans of the wars in Iraq and Afghanistan. Am J Trop Med Hyg 99: 638648. [Google Scholar]
  2. Nevin RL, , 2017. A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions. Pharmacol Res Perspect 5: e00328. [Google Scholar]
  3. Nevin RL, , 2018. Re: “A decade of war: prospective trajectories of posttraumatic stress disorder symptoms among deployed us military personnel and the influence of combat exposure”. Am J Epidemiol 187: 15731574. [Google Scholar]
  4. Nevin RL, Byrd AM, , 2016. Neuropsychiatric adverse reactions to mefloquine: a systematic comparison of prescribing and patient safety guidance in the US, UK, Ireland, Australia, New Zealand, and Canada. Neurol Ther 5: 6983. [Google Scholar]
  5. Tickell-Painter M, Maayan N, Saunders R, Pace C, Sinclair D, , 2017. Mefloquine for preventing malaria during travel to endemic areas. Cochrane Database Syst Rev 2017: CD006491. [Google Scholar]
  6. Nevin RL, , 2017. Misclassification and bias in military studies of mefloquine. Am J Trop Med Hyg 97: 305. [Google Scholar]
  7. Livezey J, Oliver T, Cantilena L, , 2016. Prolonged neuropsychiatric symptoms in a military service member exposed to mefloquine. Drug Saf Case Rep 3: 7. [Google Scholar]
  8. Nevin RL, , 2017. Screening for symptomatic mefloquine exposure among veterans with chronic psychiatric symptoms. Fed Pract 34: 1214. [Google Scholar]
  9. Nevin RL, Ritchie EC, , 2015. Mefloquine and posttraumatic stress disorder. , ed. Textbook of Military Medicine. Forensic and Ethical Issues in Military Behavioral Health. Washington, DC: Borden Institute, 277296. [Google Scholar]
  10. The Quinism Foundation, 2018. The Quinism Foundation Calls on the Department of Veterans Affairs to Screen Recent Veterans for Symptomatic Mefloquine Exposure. Available at: https://www.prweb.com/releases/2018/05/prweb15511802.htm. Accessed September 23, 2018.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0771a
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error